N-Power Medicine
N-Power Medicine combines a community-oncology care network with clinical-trial data services for cancer drug developers.
$32MSeries B
ParticipantLV
Labcorp Venture Fund
labcorp.com ↗Activity from announced rounds
Activity in this selectionallina-health-258a8846
Labcorp Venture Fund invests in healthcare innovation, including diagnostic technologies, platforms and services.
Investment focus
The fund works with founders developing more data-driven and personalized care. Its focus on diagnostic innovation links new technologies with clinical and healthcare-delivery needs.
Activity recorded by RoundOS
In RoundOS, Vitestro develops robotic diagnostic blood collection, Prenosis builds critical-care diagnostic technology, and N-Power Medicine connects community oncology with clinical research and data services. These recorded financings provide examples of healthcare activity; the list does not claim to cover the fund’s full portfolio.
Sources
- Rounds participated in
- 5
- Confirmed lead rounds
- 0 4 roles undisclosed
- New companies
- 5 First participation on record · 0 follow-on
- Funding in participating rounds
- $130M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
5 in this selectionVitestro
Develops autonomous robotic phlebotomy devices for diagnostic blood collection
$70MSeries B
Role not disclosedPrenosis
Develops integrated diagnostics and therapeutics for critical care conditions
$20MSeries A
Role not disclosedBIOMAKERS
Transforms clinical and genomic information into actionable insights for therapeutic and diagnost...
$8MUndisclosed
Role not disclosedIMVARIA
Pioneers AI-driven digital biomarker solutions for clinicians to make accurate diagnoses
UndisclosedStrategic
Role not disclosed